aXichem obtains a patent for the use of phenylcapsaicin in the treatment of leaky gut
aXichem AB (publ) (“aXichem”), that develops and markets analogue industrial compounds, has received a patent regarding the company's natural analogue capsaicin, phenylcapsaicin, and variants of the product, as a substance for the treatment of leaky gut. The patent significantly contributes to aXichem’s patent portfolio and is commercially valuable, since it protects the company's unique product in an area where phenylcapcaicin, in tests, has shown clear effectiveness.Leaky gut means that the intestinal wall's protective barrier has weakened and thus lets toxins